Overview

Preoperative Use of Montelukast Sodium

Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
Supraglottic airway equipment used during anaesthesia application can lead to airway reactivity or even larynx spasm in sensitive children. Montelukast Sodium, used in asthma treatment, is a cysteinyl leukotriene Type 1 antagonist which reduces leukotriene C4, leukotriene D4 and leukotriene E4 synthesis. The use of Montelukast Sodium in airway reactivity is known to reduce the need for bronchodilator and corticosteroids.
Phase:
Phase 4
Details
Lead Sponsor:
Umraniye Education and Research Hospital
Treatments:
Montelukast